garetosmab semaglutide GDF8 and activin A blockade protects against GLP-1–induced muscle loss while enhancing fat loss in obese male mice and non-human primates Ozempic Without Muscle Loss? New

In trials, semaglutide cut visceral fat area by 19.7%, an alteration in risk factor that independently helps reduce your heart disease risks from the inside out, independent of total weight loss

After initial use, providers are advised to keep the pen at temperatures above 86 degrees Fahrenheit, 30 degrees Celsius, or below 68F

Symptoms are often most pronounced during the initial dose titration phase and may improve as the body adjusts to treatment

The Zepbound (tirzepatide) label recommends switching to a non-oral birth control method, or adding a barrier method, for 4 weeks after starting Zepbound and for 4 weeks after each dose increase